Latest filing published 16 Jul 2026 for ECO Animal Health Group plc, €24k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +9.1%Entry £0.88 · Close 09 Oct 2026 £0.96
- -13.2%Entry £1.10 · Close 09 Oct 2026 £0.96
- -35.0%Entry £1.13 · Close at T+365 £0.74
- -32.7%Entry £1.09 · Close at T+365 £0.73
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David Hallas: trading record in brief
David Hallas discloses dealings in ECO Animal Health Group plc to RNS (LSE). Over a trading history stretching from 29 November 2022 to 16 July 2026, the count stands at 8 filings.
Every open-market trade on record is a purchase: 8 purchases worth €210k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 2 purchases and no sales on the market.
The median purchase comes to €24k. 1 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -15.9%. These figures describe past trades and do not predict future prices.
On 16 July 2026 came the latest disclosure, an open-market purchase for €24k in ECO Animal Health Group plc. Most trades are made public on the day they happen. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David Hallas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,346 shares@ £0.8950.032% mcap12.6% of flowXLON - LONDON STOCK EXCHANGE - AIMISIN GB0032036807RNS:72b4adaf-182a-4707-bd59-be3d2e58cf0dCanonical exit: 14 Oct 2026 (T+90)
- 22,346 shares@ £0.8950.032% mcap12.6% of flowXLON - LONDON STOCK EXCHANGE - AIMISIN GB0032036807RNS:9673131Canonical exit: 14 Oct 2026 (T+90)
- 18,348 shares@ £1.0912.3% of flowLondon Stock ExchangeISIN GB0032036807RNS:caf6a668-8e82-4984-86d9-13b2bdb6b6a6Canonical exit: 4 Mar 2026 (T+90)
- 29,897 shares@ £0.66912.4% of flowLondon Stock ExchangeISIN GB0032036807RNS:5739079Canonical exit: 13 Oct 2025 (T+90)
- 29,962 shares@ £0.667512.6% of flowLondon Stock ExchangeISIN GB0032036807RNS:5630603Canonical exit: 24 Jul 2025 (T+90)
- 18,181 shares@ £1.1012.7% of flowLondon Stock Exchange, AIMRNS:5329762Canonical exit: 28 Nov 2024 (T+90)
- 37,759 shares@ £1.05924.8% of flowLondon Stock Exchange, AIMRNS:4988135Canonical exit: 28 Feb 2024 (T+90)
7 of 7 declarations